顯示所有 12 筆結果
-
Anti-CD20 [10F381 (rituximab)] (Ab00126-35.0-BT)
-
Anti-CD20 [10F381 (rituximab)] (Ab00126-35.0)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-35.0-BT)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-35.0)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-36.0-BT)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-36.0)
-
Anti-CD52 [Campath-1H] (Ab00124-35.0-BT)
-
Anti-CD52 [Campath-1H] (Ab00124-35.0)
-
Anti-IL-2R [Daclizumab] (Ab00187-35.0-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-35.0)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-35.0-BT)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-35.0)
